The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.

Analyst Naz Rahman of Maxim Group reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target of ...

Viking Therapeutics (VKTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Viking Therapeutics has announced positive results from its Phase Ib clinical trial of VK0214, a thyroid hormone receptor ...

Alger Small Cap Growth Fund highlighted stocks like Viking Therapeutics, Inc. (NASDAQ:VKTX), in the first quarter 2024 ...

Baron Health Care Fund highlighted stocks like Viking Therapeutics, Inc. (NASDAQ:VKTX), in the second quarter 2024 investor ...

These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.

Local markets finished the week flat, despite momentum among the goldies and InfoTech stocks, and a boost for lithium on ...

Two more murals — and seven decorated utility boxes — are being installed by local artists along the First Avenue corridor in ...

After an epic election defeat in July, opposition lawmakers have presented their party’s dues-paying members with an unexpected choice of two candidates from the right. By Mark Landler and ...

Harris leads Trump among voters in the vast middle of American society by 47% to 41%. Environmentcategory Hurricane Milton spawns tornadoes, leaves millions without power in Florida 12:22 PM UTC ...

2 teams suing NASCAR ask court to compete under new charter agreement (October 9, 2024, 11:47 AM ET) ...